N-(1h-benzo[d]imidazol-2-yl)-3-nitrobenzamide;N-(1H-Benzimidazol-2-yl)-3-nitrobenzamide;Cambridge id 7283005;Oprea1_384876;Oprea1_144350;MLS000418401;QPKROMNIEAEFQA-UHFFFAOYSA-N;STK433528;BDBM50184701;SMR000264931;ST50927847;3-nitro-N-(1H-benzoimidazol-2-yl)-benzamide;N-benzimidazol-2-yl(3-nitrophenyl)carboxamide;N-(1H-1,3-benzodiazol-2-yl)-3-nitrobenzamide;Z27666143;N-1,3-dihydro-2;IRAK-4 protein kinase inhibitor 2
IRAK-4 protein kinase inhibitor 2 (compound 1) is a potent inhibitor of interleukin-1 (IL-1) receptor-associated kinase-4 (IRAK-4), with an IC 50 of 4 μM. IRAK-4 protein kinase inhibitor 2 can be used for the research of inflammatory and immune-related conditions or disorders.
性状
Solid
IC50 & Target[1][2]
IRAK4 4 μM (IC50)
体外研究(In Vitro)
IRAK-4 protein kinase inhibitor 2 (compound 1) also inhibits IRAK-1, with an IC50 of <10 μM. has not independently confirmed the accuracy of these methods. They are for reference only.
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
Powder -20°C 3 years;4°C 2 years
参考文献
[1]. Powers JP, et, al. Discovery and initial SAR of inhibitors of interleukin-1 receptor-associated kinase-4. Bioorg Med Chem Lett. 2006 Jun 1;16(11):2842-5.
溶解度数据
In Vitro: DMSO : 10 mg/mL (35.43 mM; Need ultrasonic)配制储备液